• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Taiwan’s China Airlines splits $11.9 billion aircraft deal between Boeing and Airbus

by December 19, 2024
written by December 19, 2024

TAIPEI (Reuters) -Taiwan’s China Airlines will split an order for its long-haul fleet renewal between Boeing (NYSE:BA) and European rival Airbus and buy freighters from the U.S. planemaker in a closely watched deal worth almost $12 billion.

Taiwan’s largest carrier had been considering the 777X, of which the 777-9 is a variant, and A350-1000 as replacements for its fleet of 10 Boeing 777-300ERs and to provide capacity for future growth, sources have told Reuters previously.

China Airlines said on Thursday that it would buy 10 Boeing 777-9 aircraft and 10 Airbus A350-1000s as well as four 777-8 freighter aircraft for $11.9 billion, with deliveries for the new aircraft starting from 2029.

“China Airlines has been actively planning its fleet size and is steadily expanding its presence in the global passenger and cargo markets,” it said in a statement.

The A350s will be powered by Rolls-Royce (OTC:RYCEY) engines while the 777-9s will be powered by GE engines, it added.

Multibillion-dollar deals for new aircraft often have to take political as well as business considerations into account – especially in the case of Taiwan, given its international situation and pressure it faces to give in to China’s sovereignty claims, which are rejected by the democratically elected government in Taipei.

The United States is Taiwan’s most important international backer and arms supplier despite a lack of formal diplomatic ties, and China Airlines’ majority owner is the Taiwan government.

China Airlines Chairman Hsieh Shih-chien said in October that the carrier was not facing any political pressure on the decision about its long-haul fleet.

China Airlines shares closed 1% down on Thursday, in line with the broader index.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Analysis-Behind a potential Honda and Nissan tie-up, the existential threat posed by Chinese EVs
next post
European stocks tumble after Fed’s hawkish signal

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • ‘Shark Tank’ alum Bombas taps former Under Armour exec as CEO as it looks beyond digital roots

      May 16, 2025
    • Netflix says its ad tier now has 94 million monthly active users

      May 15, 2025
    • Dick’s Sporting Goods to buy struggling Foot Locker for $2.4 billion

      May 15, 2025
    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (464)
    • Stock (6,426)

    Latest News

    • ‘Shark Tank’ alum Bombas taps former Under Armour exec as CEO as it looks beyond digital roots
    • Netflix says its ad tier now has 94 million monthly active users

    Popular News

    • Bain Capital ups bid for Australia’s Insignia to $1.8 billion, matching CC Capital
    • Q32 Bio: Oppenheimer slashes price targeton mixed trial results

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy